Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ricardo Martin Vidal"'
Autor:
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, Daria Vladimirova, Azza Abdelgawad, Daniela Kunecova, Xiaoyuan Lin, Geraldine Nouailles, Anne Voss, Sandra Kunder, Achim D. Gruber, Haibo Wu, Nikolaus Osterrieder, Dusan Kunec, Jakob Trimpert
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract The development of effective SARS-CoV-2 vaccines has been essential to control COVID-19, but significant challenges remain. One problem is intramuscular administration, which does not induce robust mucosal immune responses in the upper airwa
Externí odkaz:
https://doaj.org/article/ba2f95e791cc4727ac5174ea84be9eaa
Autor:
Raju Bej, Chuanxiong Nie, Kai Ludwig, Vahid Ahmadi, Jakob Trimpert, Julia M. Adler, Tatyana L Povolotsky, Katharina Achazi, Marten Kagelmacher, Ricardo Martin Vidal, Jens Dernedde, Benedikt B. Kaufer, Rainer Haag
Publikováno v:
Angewandte Chemie International Edition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e6d7dd03ba8dc80ac5da07090f8941
https://doi.org/10.1002/anie.202304010
https://doi.org/10.1002/anie.202304010
Autor:
Julia M. Adler, Ricardo Martin Vidal, Anne Voß, Sandra Kunder, Mariana Nascimento, Azza Abdelgawad, Christine Langner, Daria Vladimirova, Nikolaus Osterrieder, Achim D. Gruber, Dusan Kunec, Jakob Trimpert
Publikováno v:
Molecular Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e59ffa4e231294c66d8e553a28997d28
https://doi.org/10.1016/j.ymthe.2023.05.004
https://doi.org/10.1016/j.ymthe.2023.05.004
Autor:
Bruna Los, Marco Preußner, Kathrin Eschke, Ricardo Martin Vidal, Azza Abdelgawad, Didrik Olofsson, Sandra Keiper, Margarida Paulo-Pedro, Alica Grindel, Stefan Meinke, Jakob Trimpert, Florian Heyd
Publikováno v:
Nucleic acids research. 50(12)
Antiviral innate immunity represents the first defense against invading viruses and is key to control viral infections, including SARS-CoV-2. Body temperature is an omnipresent variable but was neglected when addressing host defense mechanisms and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f0b756efccfdc9509bd082ffe867890
https://pubmed.ncbi.nlm.nih.gov/35713540
https://pubmed.ncbi.nlm.nih.gov/35713540
Autor:
Geraldine Nouailles, Julia M. Adler, Peter Pennitz, Stefan Peidli, Gustavo Teixeira Alves, Morris Baumgart, Judith Bushe, Anne Voss, Alina Langenhagen, Fabian Pott, Julia Kazmierski, Cengiz Goekeri, Szandor Simmons, Na Xing, Christine Langner, Ricardo Martin Vidal, Azza Abdelgawad, Susanne Herwig, Günter Cichon, Daniela Niemeyer, Christian Drosten, Christine Goffinet, Markus Landthaler, Nils Blüthgen, Haibo Wu, Martin Witzenrath, Achim D. Gruber, Samantha D. Praktiknjo, Nikolaus Osterrieder, Emanuel Wyler, Dusan Kunec, Jakob Trimpert
Vaccines are a cornerstone in COVID-19 pandemic management. Here, we compare immune responses to and preclinical efficacy of the mRNA vaccine BNT162b2, an adenovirus-vectored spike vaccine, and the live-attenuated-virus vaccine candidate sCPD9 after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b0dc6876e31b59e9b8dcc55a0c9db8
https://doi.org/10.1101/2022.05.16.492138
https://doi.org/10.1101/2022.05.16.492138
